Magnitude of PD-1, PD-L1 and T lymphocyte expression on tissue from castration-resistant prostate adenocarcinoma: an exploratory analysis

F Massari, C Ciccarese, A Calio, E Munari, L Cima… - Targeted …, 2016 - Springer
Abstract Background and Aim Recent therapeutic strategies for castration-resistant prostate
cancer have focused on immunomodulation, especially the PD-1/PD-L1 pathway related to …
被引用次数：82 相关文章 Web of Science: 51

[引用][C] Magnitude of PD-1, PD-L1 and T lymphocyte expression on tissue from castration-resistant prostate adenocarcinoma: an exploratory analysis

F Massari, C Ciccarese, A Calio, E Munari… - Targeted …, 2015 - espace.library.uq.edu.au
Background and Aim: Recent therapeutic strategies for castration-resistant prostate cancer
have focused on immunomodulation, especially the PD-1/PD-L1 pathway related to tumor …

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

F Massari, C Ciccarese, A Caliò, E Munari… - Targeted …, 2016 - search.proquest.com
Results Tumor-infiltrating T lymphocytes (CD3+) were seen in 11/16 cases (69%). Nine of 16
cases expressed PD-1 (56%), among which 19% were scored 2+. Eight of 16 cases …

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

F Massari, C Ciccarese, A Calio, E Munari… - TARGETED …, 2016 - iris.unipv.it
Background and Aim Recent therapeutic strategies for castration-resistant prostate cancer
have focused on immunomodulation, especially the PD-1/PD-L1 pathway related to tumor …

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

F Massari, C Ciccarese, A Calio, E Munari… - TARGETED …, 2016 - iris.univr.it
Abstract Background and Aim Recent therapeutic strategies for castration-resistant prostate
cancer have focused on immunomodulation, especially the PD-1/PD-L1 pathway related to …

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

F Massari, C Ciccarese, A Calio, E Munari… - TARGETED …, 2016 - cris.unibo.it
Abstract Background and Aim: Recent therapeutic strategies for castration-resistant prostate
cancer have focused on immunomodulation, especially the PD-1/PD-L1 pathway related to …

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis.

F Massari, C Ciccarese, A Caliò, E Munari… - Targeted …, 2016 - europepmc.org
Results Tumor-infiltrating T lymphocytes (CD3+) were seen in 11/16 cases (69%). Nine of 16
cases expressed PD-1 (56%), among which 19% were scored 2+. Eight of 16 cases …

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

F Massari, C Ciccarese, A Calio, E Munari… - TARGETED …, 2016 - iris.unibs.it
Background and Aim Recent therapeutic strategies for castration-resistant prostate cancer
have focused on immunomodulation, especially the PD-1/PD-L1 pathway related to tumor …

[引用][C] Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

F Massari - Target Oncol, 2015 - cir.nii.ac.jp
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant
Prostate Adenocarcinoma: An Exploratory Analysis | CiNii Research CiNii 国立情報学研究所 …

Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis

F Massari, C Ciccarese, A Caliò, E Munari, L Cima… - Targeted …, 2016 - hero.epa.gov
BACKGROUND AND AIM: Recent therapeutic strategies for castration-resistant prostate
cancer have focused on immunomodulation, especially the PD-1/PD-L1 pathway related to …